TickerFacts.

A business in context

REGN research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-02 · 0001992352-26-000007

  2. 4 · Ownership change

    Report date 2026-09-02 · 0001663758-26-000002

  3. 4 · Ownership change

    Report date 2026-08-19 · 0001238303-26-000002

  4. 4 · Ownership change

    Report date 2026-08-18 · 0001697422-26-000002

  5. 4 · Ownership change

    Report date 2026-08-10 · 0001992352-26-000005

  6. 4 · Ownership change

    Report date 2026-08-10 · 0001681643-26-000006

  7. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000872589-26-000025

  8. 8-K · Current report

    Report date 2026-07-30 · 0000872589-26-000023 · Items 2.02,9.01

  9. 4 · Ownership change

    Report date 2026-07-02 · 0001187443-26-000010

  10. 8-K · Current report

    Report date 2026-07-06 · 0001104659-26-080562 · Items 2.02

  11. 8-K · Current report

    Report date 2026-06-12 · 0001104659-26-075127 · Items 5.07

  12. 4 · Ownership change

    Report date 2026-05-01 · 0001187443-26-000008

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000872589-26-000016

  14. 8-K · Current report

    Report date 2026-04-29 · 0000872589-26-000014 · Items 2.02,9.01

  15. DEF 14A · Proxy statement

    Report date 2026-06-12 · 0001308179-26-000340

  16. 8-K · Current report

    Report date 2026-04-08 · 0001104659-26-040661 · Items 2.02

  17. 10-K · Annual report

    Report date 2025-12-31 · 0000872589-26-000008

  18. 8-K · Current report

    Report date 2026-01-30 · 0000872589-26-000004 · Items 2.02,9.01

  19. 8-K · Current report

    Report date 2026-01-12 · 0001104659-26-002691 · Items 2.02,7.01,9.01

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000872589-25-000028

  21. 8-K · Current report

    Report date 2025-10-28 · 0000872589-25-000026 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2025-10-06 · 0001104659-25-096921 · Items 2.02

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000872589-25-000019

  24. 8-K · Current report

    Report date 2025-08-01 · 0000872589-25-000017 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-06-13 · 0001104659-25-060637 · Items 5.07

  26. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001804220-25-000022

  27. 8-K · Current report

    Report date 2025-04-29 · 0001804220-25-000020 · Items 2.02,9.01

  28. DEF 14A · Proxy statement

    Report date 2025-06-13 · 0001308179-25-000518

  29. 10-K · Annual report

    Report date 2024-12-31 · 0001804220-25-000011

  30. 8-K · Current report

    Report date 2025-02-04 · 0001804220-25-000007 · Items 2.02,8.01,9.01

  31. 8-K · Current report

    Report date 2025-01-13 · 0001104659-25-002826 · Items 2.02,7.01,9.01

  32. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001804220-24-000040

  33. 8-K · Current report

    Report date 2024-10-31 · 0001804220-24-000038 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2024-10-07 · 0001104659-24-106432 · Items 2.02

  35. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001804220-24-000028

  36. 8-K · Current report

    Report date 2024-08-01 · 0001804220-24-000026 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2024-07-08 · 0001104659-24-078172 · Items 2.02

  38. 8-K · Current report

    Report date 2024-06-14 · 0001104659-24-073372 · Items 5.07

  39. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001804220-24-000017

  40. 8-K · Current report

    Report date 2024-05-02 · 0001804220-24-000015 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 21 transaction rows21SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

21 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-01
2026-05-04
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2.0710.87
2026-05-01
2026-05-04
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5.0711.49
2026-05-01
2026-05-04
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1.0712.09
2026-05-01
2026-05-04
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2.0714.13
2026-05-01
2026-05-04
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4.0707.4
2026-05-01
2026-05-04
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock6.0709.45
2026-05-01
2026-05-04
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7.0706.74
2026-05-01
2026-05-04
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock14.0705.56
2026-05-01
2026-05-04
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock15.0704.28
2026-05-01
2026-05-04
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock24.0703.46
2026-05-01
2026-05-04
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5.0701.76
2026-05-01
2026-05-04
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock15.0702.46
2026-04-01
2026-04-03
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock13.0776.62
2026-04-01
2026-04-03
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock9.0777.42
2026-04-01
2026-04-03
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4.0778.24
2026-04-01
2026-04-03
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock40.0779.71
2026-04-01
2026-04-03
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock14.0775.58
2026-04-01
2026-04-03
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8.0773.59
2026-04-01
2026-04-03
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3.0772.76
2026-04-01
2026-04-03
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1.0771.32
2026-04-01
2026-04-03
RYAN ARTHUR F
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8.0774.58

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000872589REGENERON PHARMACEUTICALS, INC.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300RCBFWIRX3HYQ56
GLEIF legal name
REGENERON PHARMACEUTICALS, INC.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2025-11-24T14:16:05Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Regeneron Pharmaceuticals · alias · wikidata
  • Regeneron · alias · wikidata
  • REGENERON PHARMACEUTICALS INC · former SEC name · 1995-07-26 to 2019-06-19
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$14.20B$15.12B
2023-12-31$13.12B$14.37B
2022-12-31$12.17B$13.89B
2021-12-31$16.07B$19.80B
2020-12-31$8.50B$10.96B
2019-12-31$6.56B$8.56B
2018-12-31$5.15B$6.84B
2017-12-31$5.87B$8.00B

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗